Cloning of a TGF beta type I receptor that forms a heteromeric complex with the TGF beta type II receptor
about
Activation of signalling by the activin receptor complexIdentification of receptors and signaling pathways for orphan bone morphogenetic protein/growth differentiation factor ligands based on genomic analysesTGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4Phosphorylation of the human-transforming-growth-factor-beta-binding protein endoglinInhibin antagonizes inhibition of liver cell growth by activin by a dominant-negative mechanismPhysical and functional interactions between type I transforming growth factor beta receptors and Balpha, a WD-40 repeat subunit of phosphatase 2A.Regulation of myostatin activity and muscle growthCloning and characterization of a human type II receptor for bone morphogenetic proteinsGenomic structure and cloned cDNAs predict that four variants in the kinase domain of serine/threonine kinase receptors arise by alternative splicing and poly(A) additionSynergistic cooperation of TFE3 and smad proteins in TGF-beta-induced transcription of the plasminogen activator inhibitor-1 geneType I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor beta and activinHuman type II receptor for bone morphogenic proteins (BMPs): extension of the two-kinase receptor model to the BMPsBetaglycan can act as a dual modulator of TGF-beta access to signaling receptors: mapping of ligand binding and GAG attachment sitesGADD34-PP1c recruited by Smad7 dephosphorylates TGFbeta type I receptorActivin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesisInvestigation of three new mouse mammary tumor cell lines as models for transforming growth factor (TGF)-beta and Neu pathway signaling studies: identification of a novel model for TGF-beta-induced epithelial-to-mesenchymal transitionRole of endoglin in fibrosis and sclerodermaOligomeric interactions of TGF-β and BMP receptorsThe structure of myostatin:follistatin 288: insights into receptor utilization and heparin bindingThe T?R-I Pre-Helix Extension Is Structurally Ordered in the Unbound Form and Its Flanking Prolines Are Essential for BindingIsolation of recombinant BMP receptor IA ectodomain and its 2:1 complex with BMP-2Cloning of a novel type II serine/threonine kinase receptor through interaction with the type I transforming growth factor-beta receptorThe Discovery and Early Days of TGF-β: A Historical PerspectiveIdentification of type I and type II serine/threonine kinase receptors for growth/differentiation factor-5Analysis of the native murine bone morphogenetic protein serine threonine kinase type I receptor (ALK-3)Identification of a human type II receptor for bone morphogenetic protein-4 that forms differential heteromeric complexes with bone morphogenetic protein type I receptorsAbnormal angiogenesis but intact hematopoietic potential in TGF-beta type I receptor-deficient miceReduction in transforming growth factor-beta type II receptor in mouse lung carcinogenesisThe orphan receptor serine/threonine kinase ALK7 signals arrest of proliferation and morphological differentiation in a neuronal cell lineTGF-{beta}1 activates two distinct type I receptors in neurons: implications for neuronal NF-{kappa}B signalingAlbumin endocytosis in endothelial cells induces TGF-beta receptor II signalingOntogeny and localization of TGF-beta type I receptor expression during lung developmentIdentification of endoglin in rat hepatic stellate cells: new insights into transforming growth factor beta receptor signalingSnoN and Ski protooncoproteins are rapidly degraded in response to transforming growth factor beta signalingPhosphorylation of Ser165 in TGF-beta type I receptor modulates TGF-beta1-induced cellular responsesDifferent domains regulate homomeric and heteromeric complex formation among type I and type II transforming growth factor-beta receptors.Endoglin and Alk5 regulate epithelial-mesenchymal transformation during cardiac valve formation.A novel transforming growth factor-beta receptor-interacting protein that is also a light chain of the motor protein dynein.Enhanced tumorigenesis and reduced transforming growth factor-beta type II receptor in lung tumors from mice with reduced gene dosage of transforming growth factor-beta1.Structural basis for potency differences between GDF8 and GDF11.
P2860
Q24308084-BF8DEB65-370F-45E8-8C1B-C7F5D86F7CB2Q24310450-7A83CBEA-3191-4202-A0E4-B8B321865B5CQ24314661-2840F7AE-BF25-4812-8EB0-1D407F1D2CA9Q24316465-E8959995-8CBD-4115-AD45-DCB45EEDC38AQ24317361-4261FC37-A0E8-445A-BBA8-6B3F7A95D849Q24522790-409325EA-EF2D-455D-B577-2E4DDB2B98E1Q24555817-C61AB22F-3652-469D-8A02-56E7E47DC7F8Q24561622-19981572-EFB6-4F43-BDF0-905F826C2E2DQ24564207-056949E4-E28E-4497-81CB-22EA8FD29F96Q24596458-CD72A1FC-63E9-46F2-8C3F-AEE52238AD9EQ24612297-2044D9F9-85C9-414A-808E-E1E11A177AE3Q24651958-27C6B02F-2562-432F-BF27-B6733E970349Q24673586-081A802E-876E-41CF-BE2A-4554F39A25E7Q24676599-73EA0CCC-75F6-4D91-9181-27FC6C8A9260Q24677057-2FD9A47A-B82E-4475-B4DE-4C62B1B081B9Q24806331-6C209B5B-6D34-4B69-A2AD-E1FA9113D21CQ26821836-001FD9EB-BAC9-4B2A-9ED6-D10832DA8360Q27023170-CFC50CDA-FFE7-4D55-AC6B-2588F3B73607Q27656789-F7DAE67A-0032-4AA4-9C45-2F7DFDE95FC5Q27671571-CBA746E6-F809-4164-B623-C0788F92E5F8Q28145537-CD0DECC3-B2F4-4864-9C67-DAF14F24B978Q28236304-0DECEC20-118C-42E1-8D31-A97E0BE89C92Q28276556-09BF7181-46DE-4038-AC90-C8059AFDB021Q28284508-1671E71C-C447-4225-A760-6A5B1181CD87Q28284898-D053D84D-6E4E-48FB-8895-52F14FCD2A53Q28297386-482BDDD3-8698-4AC5-9CF8-8A41CDB087BBQ28361871-21DAD5E4-A380-4F55-9F85-F6F57ABE13F1Q28509893-4F60751A-1382-4323-8598-CAEE2856AC5CQ28567347-C4A60EE3-A958-43C9-AD4E-4FE9428306D7Q28569079-21E251ED-C0B6-4AC7-8D15-D35AE968F7D4Q28571613-199E2D27-0917-459C-A310-2EBF2611005CQ28573806-95B7BDCF-C47F-4B32-A7BD-85FC058ACE44Q28575076-7D4FB106-AE75-4666-B989-6A319B83DB19Q28608960-7C801538-CD4B-451B-BC42-645D46CFF2CBQ28631366-17FE52BE-6DE3-4362-804C-EF3F6B0EE554Q30436708-10CE0A76-842F-4011-9639-0A1EC61F74CAQ30480194-886A8AF1-387D-4517-804E-0C6AA8A367FAQ30873808-45B46FDA-98D9-4DF0-9010-4472EF60D47FQ30960344-4A194559-2C83-4ED8-B27D-9A9AE7D636F8Q31813087-90634711-33B0-4E2F-A15B-11A73DEC7AD3
P2860
Cloning of a TGF beta type I receptor that forms a heteromeric complex with the TGF beta type II receptor
description
1993 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 1993
@ast
im November 1993 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1993/11/19)
@sk
vědecký článek publikovaný v roce 1993
@cs
wetenschappelijk artikel (gepubliceerd op 1993/11/19)
@nl
наукова стаття, опублікована в листопаді 1993
@uk
مقالة علمية (نشرت في 19-11-1993)
@ar
name
Cloning of a TGF beta type I r ...... the TGF beta type II receptor
@ast
Cloning of a TGF beta type I r ...... the TGF beta type II receptor
@en
Cloning of a TGF beta type I r ...... the TGF beta type II receptor
@nl
type
label
Cloning of a TGF beta type I r ...... the TGF beta type II receptor
@ast
Cloning of a TGF beta type I r ...... the TGF beta type II receptor
@en
Cloning of a TGF beta type I r ...... the TGF beta type II receptor
@nl
prefLabel
Cloning of a TGF beta type I r ...... the TGF beta type II receptor
@ast
Cloning of a TGF beta type I r ...... the TGF beta type II receptor
@en
Cloning of a TGF beta type I r ...... the TGF beta type II receptor
@nl
P2093
P1433
P1476
Cloning of a TGF beta type I r ...... the TGF beta type II receptor
@en
P2093
C. H. Heldin
H. Yamashita
K. Miyazono
P. Franzén
P. ten Dijke
P304
P356
10.1016/0092-8674(93)90489-D
P407
P577
1993-11-19T00:00:00Z